to find minimal effective dose of dexmedetomidine in comparsion to fentanyl in spinal anaesthesia for decreasing hospital stay
Phase 4
- Conditions
- Health Condition 1: - Health Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2021/10/037061
- Lead Sponsor
- Dr SARVJEET KAUR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
age group of 25-65 years of either gender giving valid informed and written consent
patients undergoing ambulatory surgeries
ASA grade I and II
Exclusion Criteria
Patients with contraindication to spinal ananesthesia
History of anaphylaxis to local anaesthetics and Allergy to study drugs
Obese patient with BMI >30kg/m2
Patient with history such as CAD,CHF, dyrhythmias,valvular diseases,DM
Patients having history of substance abuse or psychiatric illness or chronic alcoholic
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the duration of perioperative analgesia in patients getting 5micrograms of dexmedetomidine with low dose hyperbaric bupivacaine <br/ ><br>To evaluate the duration of perioperative analgesia in patients getting 10micrograms of dexmedetomidine with low dose hyperbaric bupivacaine <br/ ><br>To evaluate the duration of perioperative analgesia in patients getting 25micrograms of dexmedetomidine with low dose hyperbaric bupivacaineTimepoint: 24hrs post operatively
- Secondary Outcome Measures
Name Time Method To compare the duration of perioperative analgesia in 5,10 micrograms dexmedetomidine and 25 micrograms fentanylTimepoint: First 24hr post operatively